![]() |
Volumn 37, Issue 2, 2001, Pages 93-99
|
Nongenomic vitamin D3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation [2]
a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COLECALCIFEROL;
DRUG DERIVATIVE;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE 1;
RETINOIC ACID;
RETINOIC ACID RECEPTOR;
RETINOID X RECEPTOR;
TRANSCRIPTION FACTOR;
COLECALCIFEROL DERIVATIVE;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL STRAIN HL 60;
DRUG EFFECT;
ENZYME ACTIVATION;
HUMAN;
KINETICS;
LETTER;
METABOLISM;
PHYSIOLOGY;
CELL ACTIVATION;
CELL CYCLE G0 PHASE;
CELL DENSITY;
CELL GROWTH;
CELL LINE;
HUMAN CELL;
SIGNAL TRANSDUCTION;
CELL CYCLE;
CELL DIFFERENTIATION;
CHOLECALCIFEROL;
ENZYME ACTIVATION;
HL-60 CELLS;
HUMANS;
KINETICS;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
MITOGEN-ACTIVATED PROTEIN KINASES;
RECEPTORS, RETINOIC ACID;
RETINOID X RECEPTORS;
TRANSCRIPTION FACTORS;
TRETINOIN;
|
EID: 0034744592
PISSN: 10712690
EISSN: None
Source Type: Journal
DOI: 10.1290/1071-2690(2001)037<0093:NVDAAE>2.0.CO;2 Document Type: Letter |
Times cited : (6)
|
References (18)
|